Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background: Current studies suggest an interaction between vascular mechanisms and neurodegenerative processes that leads to late-onset Alzheimer disease (AD). We tested whether AD pathology was associated with white matter hyperintensities (WMH) or cerebral infarcts in the oldest old individuals.
Methods: Brains from 132 subjects over 85 years old, who came to autopsy from the Vantaa 85+ population-based cohort, were scanned by postmortem MRI and examined for neuropathologic changes. Coronal images were analyzed to determine the degree of frontal and parietal periventricular WMH (PVWMH) and deep WMH (DWMH) and cerebral infarcts. Neuropathologic variables included Consortium to Establish a Registry for Alzheimer's Disease scores for neuritic plaques and Braak staging among subjects in 5 groups: normal aging (NA), borderline with insufficient AD pathology, AD, AD plus other pathology, and other primary degenerative diseases.
Results: Frontal DWMH were detected in >50% of the sample. Both frontal PVWMH and DWMH were significantly more extensive in the AD group compared to the NA group or the NA and borderline groups combined. Frontal PVWMH and DWMH were also associated with increased Braak staging (p = 0.03) and the neuritic plaque load (p = 0.01). Further analysis revealed there were a greater number of cerebral infarcts associated with frontal DWMH (p = 0.03) but not with frontal PVWMH.
Conclusions: Our study showed an association between neurofibrillary pathology and frontal PVWMH and DWMH (rather than parietal), as a surrogate of small vessel disease, particularly in very old community-dwelling individuals.
Footnotes
Study funding: Work in Newcastle is supported by the Medical Research Council (UK), the Alzheimer's Research Trust (UK), and the National Institutes of Health (NINDS).
-
- AD
- Alzheimer disease
- AGD
- argyrophilic grain disease
- CERAD
- Consortium to Establish a Registry for Alzheimer's Disease
- CVD
- cerebrovascular disease
- DLB
- dementia with Lewy bodies
- DTI
- diffusion tensor imaging
- DWMH
- deep white matter hyperintensities
- MR
- magnetic resonance
- NA
- normal aging
- PVWMH
- periventricular white matter hyperintensities
- VaD
- vascular dementia
- WM
- white matter
- WMH
- white matter hyperintensities
Supplemental data at www.neurology.org
- Received July 19, 2009.
- Accepted August 4, 2010.
- Copyright © 2010 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathologyJ. A. Schneider, R. S. Wilson, J. L. Bienias et al.Neurology, April 12, 2004 -
Articles
Neuropathologic correlates of white matter hyperintensitiesVanessa G. Young, Glenda M. Halliday, Jillian J. Kril et al.Neurology, August 06, 2008 -
Articles
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctionsD. A. Bennett, J. A. Schneider, J. L. Bienias et al.Neurology, March 07, 2005 -
Article
Antemortem MRI findings associated with microinfarcts at autopsyMekala R. Raman, Gregory M. Preboske, Scott A. Przybelski et al.Neurology, May 02, 2014